Clinical Trial Update: Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SHPL-49 Injection for safety and efficacy in acute ischemic stroke has completed, reporting results from participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• SHPL-49 Injection (SHPL-49)

Snippet

Sponsor: Shanghai Hutchison Pharmaceuticals Limited | Conditions: Acute Ischemic Stroke | Phase 2 | Status: COMPLETED